Karina Calzadilla | Vice President of Investor Relations |
Chad Robins | Chief Executive Officer and Co-Founder |
Kyle Piskel | Interim Chief Financial Officer |
Sharon Benzeno | Chief Commercial Officer, Immune Medicine |
Nitin Sood | Chief Commercial Officer, MRD |
Harlan Robins | Chief Scientific Officer |
Brian Weinstein | William Blair |
Elizabeth Webster | Goldman Sachs |
Mark Massaro | BTIG |
Derik de Bruin | Bank of America |
00:03 Ladies and gentlemen, thank you for standing by. And welcome to the Adaptive Biotechnologies First Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. [Operator Instructions] 00:30 I would now like to hand the conference over to your speaker today Karina Calzadilla, Head of Investor Relations.